Targeting the NPY/NPY1R Signaling Axis in Mutant p53-Dependent Pancreatic Cancer Impairs Metastasis

Scientists showed that expression of neuropeptide Y (NPY) and NPY1R were upregulated in mouse pancreatic cancer (PC) models and human patients with PC.